KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 138 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,234,791 | +13.7% | 1,176,710 | +93.9% | 0.03% | -5.9% |
| Q2 2023 | $1,086,011 | -53.0% | 606,710 | +2.2% | 0.03% | -52.1% |
| Q1 2023 | $2,309,901 | -99.8% | 593,805 | +118.9% | 0.07% | +153.6% |
| Q3 2022 | $1,481,000,000 | +44.3% | 271,219 | +19.2% | 0.03% | +86.7% |
| Q2 2022 | $1,026,000,000 | +224.7% | 227,599 | +658.7% | 0.02% | +150.0% |
| Q3 2015 | $316,000,000 | -58.7% | 30,000 | +20.0% | 0.01% | -62.5% |
| Q1 2015 | $765,000,000 | – | 25,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |